{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:26:15Z","timestamp":1790886375605,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>\n                    \u201cMixed endometrioid adenocarcinoma and adenosarcoma\u201d is a recently described malignancy of the uterus and ovary characterized by discrete components of Mullerian adenosarcoma and typically low-grade endometrioid adenocarcinoma. Its molecular biology, natural history, and proper classification remain uncertain. We analyzed clinicopathologic data and performed comparative molecular analysis on the adenocarcinomatous and adenosarcomatous components of 14 tumors using a 168-gene next-generation sequencing panel (n=11) and the MSK-IMPACT assay (n=3). Thirteen tumors were stage I, and 1 stage II. The epithelial component was endometrioid carcinoma in 12 (86%), endometrioid intraepithelial neoplasia in 1 (7%), and mesonephric-like adenocarcinoma in 1. The adenosarcomatous component showed sarcomatous overgrowth in 8 (57%), high-grade atypia in 4 (29%), heterologous differentiation in 10 (71%), and lymphovascular invasion in 3 (21%). The adenocarcinomatous and adenosarcomatous components shared molecular alterations in all cases, including mutations in\n                    <jats:italic toggle=\"yes\">ARID1A<\/jats:italic>\n                    (10, 71%),\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    (8, 57%),\n                    <jats:italic toggle=\"yes\">DICER1<\/jats:italic>\n                    (7, 50%),\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    (7, 50%),\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    (6, 43%), and\n                    <jats:italic toggle=\"yes\">PIK3R1<\/jats:italic>\n                    (4, 29%). Twelve tumors were of no specific molecular profile and 2 were microsatellite instability-high. Four (31%) patients recurred, and 3 (23%) died of disease 7, 8, and 18 months after hysterectomy. Prognosis correlated with high-risk morphologic features in the adenosarcomatous component, including sarcomatous overgrowth, extensive rhabdomyosarcomatous differentiation, vascular invasion, and high-grade nuclear atypia. \u201cMixed endometrioid adenocarcinoma and adenosarcoma\u201d is a clonal biphasic malignant neoplasm of uncertain histogenesis, with a high frequency of\n                    <jats:italic toggle=\"yes\">DICER1<\/jats:italic>\n                    mutations.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002399","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T12:20:57Z","timestamp":1744028457000},"page":"789-799","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Comparative Molecular Profiling of \u201cMixed Endometrioid Adenocarcinoma and Adenosarcoma\u201d of the Uterus and Ovary"],"prefix":"10.1097","volume":"49","author":[{"given":"Lucy X.","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"},{"name":"Department of Pathology, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Y.","family":"Tjota","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Momeni-Boroujeni","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Ordulu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Meserve","sequence":"additional","affiliation":[{"name":"Department of Pathology, Spectrum Healthcare Partners, Portland, ME"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Skala","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Chapel","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0046-8177(90)90198-E","article-title":"Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature","volume":"21","author":"Clement","year":"1990","journal-title":"Hum Pathol"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004347-199204000-00001","article-title":"Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases","volume":"11","author":"Kaku","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000478-198901000-00004","article-title":"Mullerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases","volume":"13","author":"Clement","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/00000478-200210000-00001","article-title":"Mesodermal (mullerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature","volume":"26","author":"Eichhorn","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/PAS.0000000000000907","article-title":"High-grade Mullerian adenosarcoma: genomic and clinicopathologic characterization of a distinct neoplasm with prevalent TP53 pathway alterations and aggressive behavior","volume":"41","author":"Hodgson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.2001.6334","article-title":"Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival","volume":"83","author":"Krivak","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41379-022-01160-1","article-title":"Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors","volume":"35","author":"Momeni Boroujeni","year":"2022","journal-title":"Mod Pathol"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.4442","article-title":"Targeted genomic analysis of Mullerian adenosarcoma","volume":"235","author":"Howitt","year":"2015","journal-title":"J Pathol"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.4675","article-title":"Uterine adenosarcomas are mesenchymal neoplasms","volume":"238","author":"Piscuoglio","year":"2016","journal-title":"J Pathol"},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3389\/fonc.2020.00538","article-title":"Whole-genome sequencing and target validation analysis of Mullerian adenosarcoma: a tumor with complex but specific genetic alterations","volume":"10","author":"Ban","year":"2020","journal-title":"Front Oncol"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/modpathol.2016.99","article-title":"Genomewide copy number analysis of Mullerian adenosarcoma identified chromosomal instability in the aggressive subgroup","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41379-022-01124-5","article-title":"Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies","volume":"35","author":"Sahoo","year":"2022","journal-title":"Mod Pathol"},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/PAP.0b013e3181cfe732","article-title":"Mullerian adenosarcoma of the female genital tract","volume":"17","author":"McCluggage","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1440-1827.2011.02782.x","article-title":"Mullerian adenosarcoma with a neuroectodermal component associated with an endometriotic cyst of the ovary: a case report","volume":"62","author":"Shintaku","year":"2012","journal-title":"Pathol Int"},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/PGP.0b013e318192924d","article-title":"Coexistence of a clear cell adenocarcinoma and an adenosarcoma with a heterologous rhabdomyosarcoma in an endometriotic cyst of the ovary: a case study","volume":"28","author":"Yasuoka","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PGP.0000000000000584","article-title":"Dedifferentiated carcinoma of the endometrium associated with low-grade Mullerian adenosarcoma: a clinicopathologic case report including the immunohistochemical and molecular profile","volume":"39","author":"Bai","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004347-200301000-00015","article-title":"Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas","volume":"22","author":"Seidman","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PAS.0000000000001643","article-title":"Mixed endometrioid adenocarcinoma and Mullerian adenosarcoma of the uterus and ovary: clinicopathologic characterization with emphasis on its distinction from carcinosarcoma","volume":"45","author":"El Hallani","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays","volume":"19","author":"Kadri","year":"2017","journal-title":"J Mol Diagn"},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41379-019-0298-5","article-title":"Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia\/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma","volume":"32","author":"Chapel","year":"2019","journal-title":"Mod Pathol"},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R23-20250728","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"R24-20250728","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.4569","article-title":"Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis","volume":"237","author":"Chen","year":"2015","journal-title":"J Pathol"},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"da Silva","year":"2021","journal-title":"Mod Pathol"},{"key":"R26-20250728","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PGP.0000000000000287","article-title":"Involvement of chromosome 8 in Mullerian adenosarcoma","volume":"36","author":"Howitt","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R28-20250728","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"key":"R30-20250728","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PGP.0000000000000996","article-title":"SMARCA4\/BRG1-deficient uterine neoplasm with hybrid adenosarcoma and carcinoma features: expanding the molecular-morphologic spectrum of SMARCA4-driven gynecologic malignancies","volume":"43","author":"Wei","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R31-20250728","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jcp.55.5.321","article-title":"Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?","volume":"55","author":"McCluggage","year":"2002","journal-title":"J Clin Pathol"},{"key":"R32-20250728","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pathol-020117-043609","article-title":"Molecular genetics of endometrial carcinoma","volume":"14","author":"Bell","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"R33-20250728","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R34-20250728","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00428-018-02516-2","article-title":"Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma","volume":"474","author":"Cuevas","year":"2019","journal-title":"Virchows Arch"},{"key":"R35-20250728","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ygyno.2018.04.005","article-title":"Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy\/curettage or hysterectomy specimens","volume":"149","author":"Chapel","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R36-20250728","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/PAS.0000000000000544","article-title":"Clinicopathologic comparison of Lynch syndrome-associated and \u201cLynch-like\u201d endometrial carcinomas identified on universal screening using mismatch repair protein immunohistochemistry","volume":"40","author":"Mills","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R37-20250728","first-page":"PO.17.00073","article-title":"Landscape of Microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"R38-20250728","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"R39-20250728","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41379-018-0132-5","article-title":"DICER1 mutations are frequent in mullerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation","volume":"32","author":"Bean","year":"2019","journal-title":"Mod Pathol"},{"key":"R40-20250728","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/PAP.0000000000000351","article-title":"DICER1-associated tumors in the female genital tract: molecular basis, clinicopathologic features, and differential diagnosis","volume":"29","author":"Han","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R41-20250728","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.gore.2017.04.004","article-title":"Endometrial adenosarcoma in the setting of a germline DICER1 mutation: a case report","volume":"20","author":"Mullen","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"R43-20250728","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"key":"R44-20250728","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-019-12985-x","article-title":"Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma","volume":"10","author":"Gotoh","year":"2019","journal-title":"Nat Commun"},{"key":"R45-20250728","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","article-title":"Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma","volume":"174","author":"Rios-Doria","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R46-20250728","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PGP.0000000000001010","article-title":"Endometrial carcinosarcomas are almost exclusively of p53abn molecular subtype after exclusion of mimics","volume":"43","author":"Huvila","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R47-20250728","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s12253-020-00829-9","article-title":"TCGA classification of endometrial cancer: the place of carcinosarcoma","volume":"26","author":"Travaglino","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"R48-20250728","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0000000000000671","article-title":"Corded and hyalinized endometrioid adenocarcinoma (CHEC) of the uterine corpus are characterized by CTNNB1 mutations and can show adverse clinical outcomes","volume":"40","author":"Ladwig","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R49-20250728","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/PAS.0000000000001737","article-title":"Corded and hyalinized and spindled endometrioid endometrial carcinoma: a clinicopathologic and molecular analysis of 9 tumors based on the TCGA classifier","volume":"45","author":"Safdar","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R50-20250728","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PGP.0000000000000997","article-title":"Synchronous bilateral ovarian mesonephric-like adenocarcinomas with separate origins from high-grade Mullerian adenosarcoma and endometriosis: report of a rare case","volume":"43","author":"Zhao","year":"2024","journal-title":"Int J Gynecol Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:00:28Z","timestamp":1753700428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002399"}},"subtitle":["A Multi-institutional Series of 14 Cases"],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002399","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}